Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Edetate?Trisodium

SKU: orb1226174

Description

Ethylenediaminetetraacetic acid (EDTA) trisodium salt is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia.

Images & Validation

Key Properties

CAS Number150-38-9
MW358.19
Purity>98% (HPLC)
FormulaC10H13N2Na3O8
SMILESO.O.[Na+].[Na+].[Na+].OC(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
Targetmetal ion
SolubilitySoluble in Water

Bioactivity

In Vivo
Animal model: Male Wistar rat model of cirrhosis induced by CCl4. Dosage: 60 mg/kg, 120 mg/kg, 240 mg/kg. Administration: Intraperitoneal injection (i.p.); Three times per week for 3 weeks (during this period, CCl4 administration continued). After CCl4 and mineral oil mixture treatment (200 μL/mouse; i.p.; Three times per week for eight weeks). Result: Kept kept all the rats alive at the 60 mg/kg dose, but died at 120 and 240 mg/kg. Reduced fibrosis of the liver in surviving rats (20%). Animal model: Male Wistar rat model of cirrhosis induced by CCl. Dosage: 60 mg/kg. Administration: Intraperitoneal injection (i.p.); Three times per week for 11 weeks. (Preventive Ethylenediaminetetraacetic acid (EDTA) group: EDTA and CCl4 were administered during 11 weeks, three times per week on alternate days). Intraperitoneal injection (i.p.); Three times per week. After CCl4 treatment (i.p.; Three times per week for eight weeks) (Therapeutic EDTA group: EDTA and CCl4 were administered for 3 weeks, three times per week on alternate days). Result: Increased sod activity by 50% in the preventive EDTA group. (Compared with untreated EDTA group). Increased Cp activity in the preventive EDTA (30%) and therapeutic EDTA (20%) groups. (Compared with the fibrotic group)Decreased mRNA expression of the pro-inflammatory molecule (TNF-α and LI-6) and the profibrogenic molecules (TGF-β and αCOLI) in both the prevention and treatment groups.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

500 mg
$ 80.00
1 g
$ 90.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry